Association Between Premenstrual Dysphoric Disorder and ADHD/ASD: A Review of Current Evidence
References
- Cary E, Simpson P. Premenstrual disorders and PMDD – a review. Best Pract Res Clin Endocrinol Metab. 2024 Jan;38(1):101858. doi: 10.1016/j.beem.2023.101858. Epub 2023 Dec 28. PMID: 38182436.
- American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders (5th edn), Text Revision (DSM-5-TR). APA, 2022.
- Arshed A, Madanes S, Pottinger S, Ackerman MG, Deutch AB. Menstrual management in transgender and gender diverse individuals: psychiatric and psychosocial considerations. Front Psychiatry. 2024 Oct 29;15:1422333. doi: 10.3389/fpsyt.2024.1422333. PMID: 39534608; PMCID: PMC11554503.
- Heinemann LA, Do Minh T, Filonenko A, Uhl-Hochgräber K. Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life. Patient. 2010 Jun 1;3(2):125–32. doi: 10.2165/11533750-000000000-00000. PMID: 22273361.
- Yang M, Wallenstein G, Hagan M, Guo A, Chang J, Kornstein S. Burden of premenstrual dysphoric disorder on health-related quality of life. J Womens Health (Larchmt). 2008 Jan–Feb;17(1):113–21. doi: 10.1089/jwh.2007.0417. PMID: 18240988.
- Osborn E, Brooks J, O’Brien PMS, Wittkowski A. Suicidality in women with Premenstrual Dysphoric Disorder: a systematic literature review. Arch Womens Ment Health. 2021 Apr;24(2):173–184. doi: 10.1007/s00737-020-01054-8. Epub 2020 Sep 16. PMID: 32936329; PMCID: PMC7979645.
- Prasad D, Wollenhaupt-Aguiar B, Kidd KN, de Azevedo Cardoso T, Frey BN. Suicidal Risk in Women with Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Systematic Review and Meta-Analysis. J Womens Health (Larchmt). 2021 Dec;30(12):1693–1707. doi: 10.1089/jwh.2021.0185. Epub 2021 Aug 20. PMID: 34415776; PMCID: PMC8721500.
- Hantsoo L, Epperson CN. Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neurobiol Stress. 2020 Feb 4;12:100213. doi: 10.1016/j.ynstr.2020.100213. PMID: 32435664; PMCID: PMC7231988.
- Bäckström T, Haage D, Löfgren M, Johansson IM, Strömberg J, Nyberg S, Andréen L, et al. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience. 2011 Sep 15;191:46–54. doi: 10.1016/j.neuroscience.2011.03.061. Epub 2011 May 13. PMID: 21600269.
- Yen JY, Lin PC, Hsu CJ, Lin C, Chen IJ, Ko CH. Attention, response inhibition, impulsivity, and decision-making within luteal phase in women with premenstrual dysphoric disorder. Arch Womens Ment Health. 2023 Jun;26(3):321–330. doi: 10.1007/s00737-023-01311-6. Epub 2023 Apr 3. PMID: 37010619.
- Lin PC, Ko CH, Yen JY. Early and Late Luteal Executive Function, Cognitive and Somatic Symptoms, and Emotional Regulation of Women with Premenstrual Dysphoric Disorder. J Pers Med. 2022 May 18;12(5):819. doi: 10.3390/jpm12050819. PMID: 35629240; PMCID: PMC9147888.
- Wynchank D, Sutrisno RMGTMF, van Andel E, Kooij JJS. Menstrual Cycle-Related Hormonal Fluctuations in ADHD: Effect on Cognitive Functioning-A Narrative Review. J Clin Med. 2025 Dec 24;15(1):121. doi: 10.3390/jcm15010121. PMID: 41517370; PMCID: PMC12786913.
- Eng AG, Nirjar U, Elkins AR, Sizemore YJ, Monticello KN, Petersen MK, et al. Attention-deficit/hyper-activity disorder and the menstrual cycle: Theory and evidence. Horm Behav. 2024 Feb;158:105466. doi: 10.1016/j.yhbeh.2023.105466. Epub 2023 Nov 30. PMID: 38039899; PMCID: PMC10872410.
- Bürger I, Erlandsson K, Borneskog C. Perceived associations between the menstrual cycle and Attention Deficit Hyperactivity Disorder (ADHD): A qualitative interview study exploring lived experiences. Sex Reprod Healthc. 2024 Jun;40:100975. doi: 10.1016/j.srhc.2024.100975. Epub 2024 Apr 25. PMID: 38678676.
- de Jong M, Wynchank DSMR, van Andel E, Beekman ATF, Kooij JJS. Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage. Front Psychiatry. 2023 Dec 13;14:1306194. doi: 10.3389/fpsyt.2023.1306194. PMID: 38152361; PMCID: PMC10751335.
- Roberts B, Eisenlohr-Moul T, Martel MM. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018 Feb;88:105–114. doi: 10.1016/j.psyneuen.2017.11.015. Epub 2017 Nov 28. PMID: 29197795; PMCID: PMC5803442.
- Moseley RL, Druce T, Turner-Cobb JM. ‘When my autism broke’: A qualitative study spotlighting autistic voices on menopause. Autism. 2020 Aug;24(6):1423–1437. doi: 10.1177/1362361319901184. Epub 2020 Jan 31. PMID: 32003226; PMCID: PMC7376624.
- Moseley RL, Druce T, Turner-Cobb JM. Autism research is ‘all about the blokes and the kids’: Autistic women breaking the silence on menopause. Br J Health Psychol. 2021 Sep;26(3):709–726. doi: 10.1111/bjhp.12477. Epub 2020 Sep 30. PMID: 32996665.
- Groenman AP, Torenvliet C, Radhoe TA, Agelink van Rentergem JA, Geurts HM. Menstruation and menopause in autistic adults: Periods of importance? Autism. 2022 Aug;26(6):1563–1572. doi: 10.1177/13623613211059721. Epub 2021 Nov 26. PMID: 34825585; PMCID: PMC9344571.
- Dorani F, Bijlenga D, Beekman ATF, van Someren EJW, Kooij JJS. Prevalence of hormone-related mood disorder symptoms in women with ADHD. J Psychiatr Res. 2021 Jan;133:10–15. doi: 10.1016/j.jpsychires.2020.12.005. Epub 2020 Dec 3. PMID: 33302160.
- Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. J Womens Health Gend Based Med. 1999 Oct;8(8):1043–52. doi: 10.1089/jwh.1.1999.8.1043. PMID: 10565662.
- Broughton T, Lambert E, Wertz J, Agnew-Blais J. Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey study. Br J Psychiatry. 2025 Jun;226(6):410–417. doi: 10.1192/bjp.2025.104. Epub 2025 Jun 18. PMID: 40528384; PMCID: PMC7617793.
- Lin PC, Long CY, Ko CH, Yen JY. Comorbid Attention Deficit Hyperactivity Disorder in Women with Premenstrual Dysphoric Disorder. J Womens Health (Larchmt). 2024 Sep;33(9):1267–1275. doi: 10.1089/jwh.2023.0907. Epub 2024 Jun 5. PMID: 38836765.
- Tsuji R, Watanabe K, Egawa M, Ito Y, Kanamori Y, Iida M, et al. Association of ADHD/ASD traits with premenstrual dysphoric disorder among full-time employed women in Japan: A cross-sectional study. J Psychiatr Res. 2026 Jan;192:371–377. doi: 10.1016/j.jpsychires.2025.10.059. Epub 2025 Nov 1. PMID: 41197219.
- Kondo C, Ihara H, Ogata H, Saima S, Nakane E. Association between premenstrual syndrome or premenstrual dysphoric disorder and presence of ASD or ADHD among adolescent females: a retrospective study. Arch Womens Ment Health. 2025 Dec;28(6):1483–1490. doi: 10.1007/s00737-025-01602-0. Epub 2025 Jul 23. PMID: 40699321.
- Obaydi H, Puri BK. Prevalence of premenstrual syndrome in autism: a prospective observer-rated study. J Int Med Res. 2008 Mar–Apr;36(2):268–72. doi: 10.1177/147323000803600208. PMID: 18380936.
- Milner V, Colvert E, Mandy W, Happé F. A comparison of self-report and discrepancy measures of camouflaging: Exploring sex differences in diagnosed autistic versus high autistic trait young adults. Autism Res. 2023 Mar;16(3):580–590. doi: 10.1002/aur.2873. Epub 2022 Dec 9. PMID: 36490366; PMCID: PMC10946751.
- Surman CB, Biederman J, Spencer T, Miller CA, McDermott KM, Faraone SV. Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study. Atten Defic Hyperact Disord. 2013 Sep;5(3):273–81. doi: 10.1007/s12402-012-0100-8. Epub 2013 Feb 15. PMID: 23413201; PMCID: PMC4009378.
- Wynchank D, Ten Have M, Bijlenga D, Penninx BW, Beekman AT, Lamers F, et al. The Association Between Insomnia and Sleep Duration in Adults With Attention-Deficit Hyperactivity Disorder: Results From a General Population Study. J Clin Sleep Med. 2018 Mar 15;14(3):349–357. doi: 10.5664/jcsm.6976. PMID: 29458702; PMCID: PMC5837836.
- Sepede G, Sarchione F, Matarazzo I, Di Giannantonio M, Salerno RM. Premenstrual Dysphoric Disorder Without Comorbid Psychiatric Conditions: A Systematic Review of Therapeutic Options. Clin Neuropharmacol. 2016 Sep–Oct;39(5):241–61. doi: 10.1097/WNF.0000000000000173. PMID: 27454391.
- Manter MA, Birtwell KB, Bath J, Friedman NDB, Keary CJ, Neumeyer AM, et al. Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms. BMC Med. 2025 Jan 7;23(1):11. doi: 10.1186/s12916-024-03814-0. PMID: 39773705; PMCID: PMC11705908.
Language: English
Page range: 33 - 51
Accepted on: Apr 27, 2026
Published on: Jun 6, 2026
Published by: The Medical Library named after S. Konopka in Warsaw
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Related subjects:
© 2026 Aleksandra Suchołbiak, Oskar Mikołajczyk, Karolina Baran, Aleksandra Serafin, published by The Medical Library named after S. Konopka in Warsaw
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.